Innovating Works

ISTRAZIVACKO RAZVOJNI CENTAR ZA BIOINZEN...

Desconocido
STRATIFYHF: Artificial intelligence-based decision support system for risk stratification and early detection of... ISTRAZIVACKO RAZVOJNI CENTAR ZA BIOINZENJERING BIOIRC DOO tramitó un HORIZON EUROPE HORIZON-HLTH-2022-STAYHLTH-01-two-stage Heart failure (HF) is a pandemic currently affecting up to 15 million people in Europe. It is a complex clinical syndrome presenting with im...
2023-06-01 - 2027-05-31 | Financiado
DECODE: Drug coated balloon simulation and optimization system for the improved treatment of peripheral arte... ISTRAZIVACKO RAZVOJNI CENTAR ZA BIOINZENJERING BIOIRC DOO participó en un H2020 H2020-MSCA-ITN-2020 DECODE will focus on the training of young scientists on the use of drug-eluting devices to combat the burden of peripheral artery disease (...
2020-08-20 - 2024-12-31 | Financiado
SILICOFCM: In Silico trials for drug tracing the effects of sarcomeric protein mutations leading to familial ca... ISTRAZIVACKO RAZVOJNI CENTAR ZA BIOINZENJERING BIOIRC DOO tramitó un H2020 H2020-SC1-2016-2017 According to the 2014 European Society of Cardiology Guidelines, cardiomyopathies are defined as structural and functional abnormalities of...
2018-05-08 - 2022-02-28 | Financiado
TAXINOMISIS: A multidisciplinary approach for the stratification of patients with carotid artery disease ISTRAZIVACKO RAZVOJNI CENTAR ZA BIOINZENJERING BIOIRC DOO participó en un H2020 H2020-SC1-2016-2017 Carotid artery disease, the primary trigger of ischaemic cerebrovascular events including stroke, causes major morbidity, mortality and heal...
2017-11-22 - 2023-12-31 | Financiado
HOLOBALANCE: HOLOgrams for personalised virtual coaching and motivation in an ageing population with BALANCE diso... ISTRAZIVACKO RAZVOJNI CENTAR ZA BIOINZENJERING BIOIRC DOO participó en un H2020 H2020-SC1-2016-2017 The overall objective of HOLOBALANCE is to develop and validate a new personalized hologram coach platform for virtual coaching, motivation...
2017-11-10 - 2021-09-30 | Financiado
InSilc: InSilc In silico trials for drug eluting BVS design development and evaluation ISTRAZIVACKO RAZVOJNI CENTAR ZA BIOINZENJERING BIOIRC DOO participó en un H2020 H2020-SC1-2016-2017 The aim of InSilc is to develop an in-silico clinical trial (ISCT) platform for designing, developing and assessing drug-eluting bioresorbab...
2017-10-16 - 2021-04-30 | Financiado
HarmonicSS: HARMONIzation and integrative analysis of regional national and international Cohorts on primary Sj... ISTRAZIVACKO RAZVOJNI CENTAR ZA BIOINZENJERING BIOIRC DOO participó en un H2020 H2020-SC1-2016-2017 HarmonicSS vision is to create an International Network and Alliance of partners and cohorts, entrusted with the mission of addressing the u...
2016-12-01 - 2020-12-31 | Financiado
SIFEM: Semantic Infostructure interlinking an open source Finite Element tool and libraries with a model re... ISTRAZIVACKO RAZVOJNI CENTAR ZA BIOINZENJERING BIOIRC DOO participó en un FP7 The clinical evidence indicates that the number of people with all levels of hearing impairment and hearing loss is rising mainly due to a g...
Financiado
EMBalance: A Decision Support System incorporating a validated patient specific multi scale Balance Hypermodel... ISTRAZIVACKO RAZVOJNI CENTAR ZA BIOINZENJERING BIOIRC DOO participó en un FP7 Human balance is achieved and maintained by a complex set of sensorimotor systems that include sensory input from vision, proprioception and...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.